ketanserin has been researched along with Adenoma, Prostatic in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hørby, J | 1 |
| Gyrtrup, HJ | 1 |
| Frimodt-Møller, C | 2 |
| Mathiesen, FR | 2 |
| Hørby-Petersen, J | 1 |
| Schmidt, PF | 1 |
| Meyhoff, HH | 1 |
2 other studies available for ketanserin and Adenoma, Prostatic
| Article | Year |
|---|---|
The effect of a serotonin antagonist ketanserin on acute urinary retention.
Topics: Acute Disease; Aged; Humans; Ketanserin; Male; Prostatic Hyperplasia; Urination Disorders; Urine | 1989 |
The effects of a new serotonin receptor antagonist (ketanserin) on lower urinary tract function in patients with prostatism.
Topics: Aged; Blood Pressure; Humans; Ketanserin; Male; Middle Aged; Piperidines; Pressure; Prostatic Hyperp | 1985 |